Pharmacokinetic Study of Vitreous and Serum Concentrations of Triamcinolone Acetonide After Posterior Sub-Tenon’s Injection

Jan 12, 2017 by in OPHTHALMOLOGY Comments Off on Pharmacokinetic Study of Vitreous and Serum Concentrations of Triamcinolone Acetonide After Posterior Sub-Tenon’s Injection

Purpose To compare a theoretical pharmacokinetic model of triamcinolone acetonide after posterior sub-Tenon’s injection with experimental serum and undiluted vitreous triamcinolone acetonide concentrations obtained during pars plana vitrectomy. Design Clinical-practice,…

read more

Graft Rejection Following Descemet Stripping Automated Endothelial Keratoplasty: Features, Risk Factors, and Outcomes

Jan 12, 2017 by in OPHTHALMOLOGY Comments Off on Graft Rejection Following Descemet Stripping Automated Endothelial Keratoplasty: Features, Risk Factors, and Outcomes

Purpose To investigate the clinical features, risk factors, and treatment outcomes following immunologic graft rejection in eyes that have undergone Descemet stripping automated endothelial keratoplasty (DSAEK). Design Retrospective case review….

read more

Surgical and Visual Outcomes of the Type I Boston Keratoprosthesis for the Management of Aniridic Fibrosis Syndrome in Congenital Aniridia

Jan 12, 2017 by in OPHTHALMOLOGY Comments Off on Surgical and Visual Outcomes of the Type I Boston Keratoprosthesis for the Management of Aniridic Fibrosis Syndrome in Congenital Aniridia

Purpose To report the clinical features and surgical management of aniridic fibrosis syndrome using the type I Boston Keratoprosthesis (KPro). Design Interventional case series. Methods Retrospective chart review of 9…

read more

AJO History of Ophthalmology Series

Jan 12, 2017 by in OPHTHALMOLOGY Comments Off on AJO History of Ophthalmology Series

The search for an effective treatment for retinal detachment involved many false hypotheses and misconceived surgical techniques, even after De Wecker and Leber in 1875 and 1882 proposed that retinal…

read more

Reduced-Fluence Photodynamic Therapy Combined With Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

Jan 12, 2017 by in OPHTHALMOLOGY Comments Off on Reduced-Fluence Photodynamic Therapy Combined With Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

Purpose To evaluate the efficacy and safety of reduced-fluence photodynamic therapy (PDT) combined with bevacizumab for polypoidal choroidal vasculopathy (PCV). Design Prospective, noncomparative, interventional case series. Methods Sixteen treatment-naïve patients…

read more
Get Clinical Tree app for offline access